Apr 16, 2026 | Blog
A familiar narrative in global health frames the pharmaceutical industry and global health priorities as fundamentally opposed: one driven by profit, the other by people. It is a compelling framing, but one that is often too simplistic to be useful. The more important...
Apr 9, 2026 | Blog
Growth in African clinical research is becoming more visible. More studies are being placed, more partnerships are being announced, and regulatory systems in several countries are evolving. But beneath that momentum sits a quieter question: what determines whether...
Apr 7, 2026 | Blog
World Health Day 2026: A Call to Action Every year on 7 April, World Health Day creates an opportunity to reflect on urgent health challenges and renew commitment to stronger, more equitable health systems. In 2026, the World Health Organization’s theme, “Together...
Apr 1, 2026 | Blog
Africa carries roughly a quarter of the world’s disease burden, yet in 2023 just 1.1% of clinical trials initiated globally were hosted on the continent (1). The infrastructure argument, regulatory gaps, ethics review timelines, laboratory Capaci, is familiar...
Mar 25, 2026 | Blog
Clinical trials remain essential to medical evidence generation. They are critical for establishing whether new interventions are safe and effective under controlled conditions. But for African health systems and life sciences strategy, trial data alone is not enough....
Mar 24, 2026 | Blog
World TB Day: Ending Tuberculosis Requires Science, Not Just Treatment Each year on 24 March, World TB Day draws attention to tuberculosis (TB), which remains one of the world’s deadliest infectious diseases. In 2024, an estimated 10.7 million people fell ill with TB...
Mar 20, 2026 | Article
For decades, Africa has often been portrayed as a continent trying to “catch up” with the rest of the world in science, healthcare, and innovation. But a growing movement among African scientists, institutions, and global partners suggests a different narrative...
Mar 19, 2026 | Blog
Africa is still too often brought into drug and vaccine development late, most commonly during Phase III, post-marketing, or implementation studies. Scientifically, that is a weak model. Phase I and II studies are where development programmes establish core...
Mar 18, 2026 | Blog
Women remain underrepresented in Africa’s research workforce overall, and they are even less visible in senior academic and scientific leadership roles. UNESCO’s latest figures show that women account for about 32% of researchers in sub-Saharan Africa, although...
Mar 13, 2026 | Blog
Ethics in clinical research has never been a matter of paperwork alone. Yet in practice, ethical quality is still too often judged by whether the right forms were signed, the right approvals were secured, and the protocol was followed on paper. Across African research...
